Fusion Antibodies - Placing to Raise £3m
FAB Wed, 06 May 2020, 08:10am BST
Fusion Antibodies is a Contract Research Organisation (CRO) established in 2001 and offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Industry: Health Care
Paul Kerr, CEO of Fusion Antibodies, talks about the company's recent placing to raise £3m along with an update around Covid-19 and plans for the rest of the year.